{"organizations": [], "uuid": "42fbd4de3cab4fa3580ce46c6f84150e2da4400e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180419.html", "section_title": "Archive News &amp; Video for Thursday, 19 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-teva-and-pg-have-agreed-to-termina/brief-teva-and-pg-have-agreed-to-terminate-the-pgt-healthcare-partnership-idUSFWN1RW0K5", "country": "US", "domain_rank": 408, "title": "BRIEF-Teva And P&G Have Agreed To Terminate The PGT Healthcare Partnership", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-19T19:11:00.000+03:00", "replies_count": 0, "uuid": "42fbd4de3cab4fa3580ce46c6f84150e2da4400e"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-teva-and-pg-have-agreed-to-termina/brief-teva-and-pg-have-agreed-to-terminate-the-pgt-healthcare-partnership-idUSFWN1RW0K5", "ord_in_thread": 0, "title": "BRIEF-Teva And P&G Have Agreed To Terminate The PGT Healthcare Partnership", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "p&g", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "pgt healthcare", "sentiment": "negative"}, {"name": "teva", "sentiment": "negative"}, {"name": "procter & gamble co", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 19 (Reuters) - Procter & Gamble Co:\n* TEVA AND THE PROCTER & GAMBLE COMPANY HAVE AGREED TO TERMINATE THE PGT HEALTHCARE PARTNERSHIP\n* TEVA PHARMACEUTICAL INDUSTRIES LTD - NO SIGNIFICANT (MATERIAL) NET FINANCIAL TRANSFER BETWEEN TEVA AND P&G WILL RESULT FROM DISSOLUTION\n* TEVA PHARMACEUTICAL INDUSTRIES LTD - SEPARATION IS PLANNED TO TAKE EFFECT JULY 1, 2018 SUBJECT TO RECEIPT OF APPLICABLE REGULATORY APPROVALS\n* TEVA PHARMACEUTICAL INDUSTRIES LTD - SEPARATION IS NOT EXPECTED TO HAVE A MATERIAL EFFECT (IMPACT) ON TEVA’S 2018 FINANCIAL OUTLOOK\n* TEVA PHARMACEUTICAL INDUSTRIES LTD - IN 2017, COMBINED SALES FROM TEVA’S PGT OTC PRODUCTS AND TEVA NON-PGT OTC PRODUCTS WERE APPROXIMATELY $1 BILLION\n* TEVA PHARMACEUTICAL - WILL MERGE ITS OTC INTERESTS RETURNING FROM PGT WITH A PORTFOLIO OF OTC ASSETS ACQUIRED IN 2016 VIA ACTAVIS ACQUISITION Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-19T19:11:00.000+03:00", "crawled": "2018-04-20T11:22:07.000+03:00", "highlightTitle": ""}